Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OTLK Outlook Therapeutics, Inc.

休市中 05-17 16:00:00 EDT

7.78

+0.45

+6.14%

盘后7.82

+0.04+0.51%

19:21 EDT

最高7.92	最低7.18	成交量18.80万
今开7.34	昨收7.33	日振幅10.09%
总市值1.82亿	流通市值8,649万	总股本2,341万
成交额144.31万	换手率1.69%	流通股本1,112万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OTLK","market":"US","secType":"STK","nameCN":"Outlook Therapeutics, Inc.","latestPrice":7.78,"timestamp":1715976000000,"preClose":7.33,"halted":0,"volume":187970,"hourTrading":{"tag":"盘后","latestPrice":7.82,"preClose":7.78,"latestTime":"19:21 EDT","volume":4382,"amount":34142.87,"timestamp":1715988084245},"delay":0,"floatShares":11117363,"shares":23405637,"eps":-11.985376,"marketStatus":"休市中","marketStatusCode":7,"change":0.45,"latestTime":"05-17 16:00:00 EDT","open":7.34,"high":7.92,"low":7.1801,"amount":1443096.25393,"amplitude":0.100941,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.985376,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"adjPreClose":7.33,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.2,"preClose":7.33,"latestTime":"09:28 EDT","volume":1204,"amount":8668.930634,"timestamp":1715952494269},"postHourTrading":{"tag":"盘后","latestPrice":7.82,"preClose":7.78,"latestTime":"19:21 EDT","volume":4382,"amount":34142.87,"timestamp":1715988084245},"volumeRatio":0.542558},"requestUrl":"/m/hq/s/OTLK/","defaultTab":"news","newsList":[{"id":"2435197265","title":"Outlook Therapeutics Inc   预计每股亏损85美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2435197265","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435197265?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:53","pubTimestamp":1715694790,"startTime":"0","endTime":"0","summary":"   * Outlook Therapeutics Inc    将于5月16日公布截至0001年1月1日的财报，预计该公司的季度收入将没有变化。*    * LSEG的分析师平均预计Outlook Therapeutics Inc每股亏损85美分。* 华尔街对 Outlook Therapeutics Inc 的 12 个月目标价中位数为 38.00 美元，高于其最新收盘价 7.54 美元。5月14日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435766613","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报7.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435766613","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435766613?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:08","pubTimestamp":1715609308,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时08分，Outlook Therapeutics, Inc.股票出现波动，股价大幅拉升5.15%。截至发稿，该股报7.97美元/股，成交量3.475万股，换手率0.15%，振幅4.88%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Ac Immune Sa涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为52.06%、27.16%、19.11%，振幅较大的相关个股有Dbv Technologies、Tevogen Bio Holdings Inc.、Azitra Inc，振幅分别为36.84%、35.55%、29.77%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132208297a599c0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132208297a599c0d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431686641","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大涨6.05%报8.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431686641","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431686641?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:50","pubTimestamp":1714398618,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时50分，Outlook Therapeutics, Inc.股票出现异动，股价急速拉升6.05%。截至发稿，该股报8.94美元/股，成交量1.2681万股，换手率0.05%，振幅5.10%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Immunitybio, Inc.、Moolec Science Sa C/Wts 、Soleno Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为673.60%、29.79%、14.92%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Immunitybio, Inc.、Enlivex Therapeutics Ltd.，振幅分别为33.33%、29.01%、22.22%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292150197924ee64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292150197924ee64&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428340951","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428340951","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428340951?lang=zh_cn&edition=full","pubTime":"2024-04-17 23:03","pubTimestamp":1713366235,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日23时03分，Outlook Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。截至发稿，该股报9.20美元/股，成交量7.3888万股，换手率0.33%，振幅4.33%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vanda Pharmaceuticals Inc.、Viracta Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃，换手率分别为136.65%、37.64%、37.00%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Dare Bioscience, Inc.，振幅分别为80.94%、48.51%、41.02%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723035579214569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723035579214569&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426977804","title":"Outlook Therapeutics, Inc.盘中异动 早盘快速下跌5.51%报8.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426977804","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426977804?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:55","pubTimestamp":1712757327,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时55分，Outlook Therapeutics, Inc.股票出现波动，股价大幅下挫5.51%。截至发稿，该股报8.75美元/股，成交量5.4482万股，换手率0.25%，振幅2.81%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1382.44%、71.17%、28.79%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Calidi Biotherapeutics, Inc.、Silo Pharma, Inc.，振幅分别为62.83%、31.96%、24.26%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021552787e7f4e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021552787e7f4e8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426112785","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426112785","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426112785?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:01","pubTimestamp":1712678516,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日00时01分，Outlook Therapeutics, Inc.股票出现波动，股价快速上涨5.45%。截至发稿，该股报9.86美元/股，成交量15.6261万股，换手率0.72%，振幅4.60%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Acrivon Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Syros Pharmaceuticals, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为469.19%、110.41%、97.58%，振幅较大的相关个股有Mymd Pharmaceuticals, Inc.、Biophytis、Cadrenal Therapeutics, Inc.，振幅分别为50.11%、40.61%、39.14%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041000015687e7eea4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041000015687e7eea4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424846776","title":"Outlook Therapeutics, Inc.盘中异动 急速上涨5.26%报10.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424846776","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424846776?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:36","pubTimestamp":1712151395,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时36分，Outlook Therapeutics, Inc.股票出现异动，股价大幅上涨5.26%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Kintara Therapeutics, Inc.、方舟生物医药、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Addex Therapeutics Limited较为活跃，换手率分别为268.17%、90.14%、16.54%，振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、Tracon Pharmaceuticals, Inc.，振幅分别为29.88%、23.39%、22.04%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032136357a50f897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032136357a50f897&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422194793","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422194793","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422194793?lang=zh_cn&edition=full","pubTime":"2024-03-28 21:36","pubTimestamp":1711632976,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日21时36分，Outlook Therapeutics, Inc.股票出现异动，股价急速上涨5.02%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Avalo Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Nutriband Inc C/Wts 涨幅较大，Avalo Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Ibio, Inc.较为活跃，换手率分别为462.57%、371.82%、365.81%，振幅较大的相关个股有Avalo Therapeutics, Inc.、Nutriband Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为71.16%、41.04%、31.00%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至21时36分，Outlook Therapeutics, Inc.股票正面舆情新闻比例20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328213617791d9d5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328213617791d9d5e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422997664","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大涨7.72%报9.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422997664","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422997664?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:32","pubTimestamp":1711546334,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时32分，Outlook Therapeutics, Inc.股票出现波动，股价急速上涨7.72%。截至发稿，该股报9.35美元/股，成交量13.4246万股，换手率0.62%，振幅1.84%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为873.43%、388.79%、48.71%，振幅较大的相关个股有Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Annexon, Inc.，振幅分别为32.17%、19.73%、15.19%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272132158b69daa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272132158b69daa9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422060510","title":"Outlook Therapeutics, Inc.盘中异动 大幅下挫5.21%报8.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422060510","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422060510?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:34","pubTimestamp":1711373670,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时34分，Outlook Therapeutics, Inc.股票出现异动，股价快速下挫5.21%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1007.97%、47.61%、31.25%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Matinas Biopharma Holdings, Inc.，振幅分别为21.97%、19.84%、11.69%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325213430791cacde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325213430791cacde&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421812888","title":"BUZZ-Outlook Therapeutics公司因欧盟药品监管机构支持其眼病药物而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2421812888","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2421812888?lang=zh_cn&edition=full","pubTime":"2024-03-22 22:09","pubTimestamp":1711116545,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月22日 - ** Outlook Therapeutics   股价上涨35.6%至9.58美元** 该公司称， (link)，欧盟药品监管机构已建议批准OTLK治疗一种名为湿性老年性黄斑变性的眼病的药物(wet AMD)** 预计欧盟委员会将在药物监管机构提出意见后的 67 天内做出批准决定。** 湿性黄斑变性是一种眼底血管异常生长的疾病，会导致视力下降** 过去 12 个月股价下跌 53","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2421191688","title":"Outlook Therapeutics, Inc.股价上涨43.89% 市值涨9596.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421191688","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421191688?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:31","pubTimestamp":1711114286,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时31分，Outlook Therapeutics, Inc.股票出现波动，股价急速拉升43.89%。截至发稿，该股报10.13美元/股，成交量657.472万股，换手率30.46%，振幅22.59%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221312687a7afa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221312687a7afa6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421045043","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大涨5.75%报7.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421045043","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421045043?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:32","pubTimestamp":1711027945,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时32分，Outlook Therapeutics, Inc.股票出现异动，股价大幅上涨5.75%。截至发稿，该股报7.17美元/股，成交量5250股，换手率0.02%，振幅2.06%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213226861e0172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213226861e0172&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420723806","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速下挫5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420723806","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420723806?lang=zh_cn&edition=full","pubTime":"2024-03-20 22:03","pubTimestamp":1710943395,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日22时03分，Outlook Therapeutics, Inc.股票出现异动，股价急速下跌5.43%。截至发稿，该股报7.00美元/股，成交量5.3596万股，换手率0.25%，振幅4.79%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.22%。其相关个股中，Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Jaguar Health, Inc.、Tc Biopharm  Plc、Nls Pharmaceutics Ltd.较为活跃，换手率分别为55.41%、35.49%、22.42%，振幅较大的相关个股有Jaguar Health, Inc.、Nls Pharmaceutics Ltd.、Taysha Gene Therapies, Inc.，振幅分别为30.33%、30.14%、25.16%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032022031587e7a677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032022031587e7a677&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472306","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌5.46%报7.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472306","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420472306?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:33","pubTimestamp":1710768784,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时33分，Outlook Therapeutics, Inc.股票出现波动，股价快速下挫5.46%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为59.19%、12.05%、6.97%，振幅较大的相关个股有Elicio Therapeutics, Inc.、2Seventy Bio, Inc.、Molecular Templates, Inc.，振幅分别为12.93%、12.72%、12.55%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182133047a4d6f2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182133047a4d6f2a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419974484","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速上涨5.58%报6.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419974484","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419974484?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:43","pubTimestamp":1710510184,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时43分，Outlook Therapeutics, Inc.股票出现波动，股价急速拉升5.58%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至21时43分，《Outlook TherapeuticsEvanson Jeff增持6.25万股普通股股份，价值约2.62万美元》资讯为影响Outlook Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315214304861deac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315214304861deac6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419602544","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大跌5.45%报6.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419602544","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419602544?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:35","pubTimestamp":1710423322,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时35分，Outlook Therapeutics, Inc.股票出现异动，股价大幅跳水5.45%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至21时35分，《Outlook TherapeuticsEvanson Jeff增持6.25万股普通股股份，价值约2.62万美元》资讯为影响Outlook Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142135227a4cb5ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142135227a4cb5ea&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419684603","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419684603","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419684603?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:33","pubTimestamp":1710336782,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时33分，Outlook Therapeutics, Inc.股票出现波动，股价快速下跌5.61%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至21时33分，《Outlook TherapeuticsEvanson Jeff增持6.25万股普通股股份，价值约2.62万美元》资讯为影响Outlook Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132133028b2e221d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132133028b2e221d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418537599","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌7.90%报0.360美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418537599","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418537599?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:32","pubTimestamp":1710250326,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时32分，Outlook Therapeutics, Inc.股票出现波动，股价快速跳水7.90%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至21时32分，《Outlook TherapeuticsEvanson Jeff增持6.25万股普通股股份，价值约2.62万美元》资讯为影响Outlook Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221320687773aee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221320687773aee&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.outlooktherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0264},{"period":"1month","weight":-0.0964},{"period":"3month","weight":-0.1386},{"period":"6month","weight":-0.1545},{"period":"1year","weight":-0.6811},{"period":"ytd","weight":-0.0127}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Outlook Therapeutics, Inc.于2010年1月5日在新泽西州注册成立。该公司是一家临床晚期生物制药公司，致力于开发首个经美国食品和药物管理局（FDA）批准用于视网膜适应症的贝伐单抗眼科制剂。他们直接或通过战略合作伙伴推出贝伐单抗，作为美国、英国、欧洲、日本等市场首个也是唯一批准的贝伐单抗，用于治疗湿性老年性黄斑变性、湿性AMD、糖尿病性黄斑水肿（DME）和视网膜分支静脉阻塞，他们正在就ONS-5010的许可和共同开发权进行积极的后期讨论。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.120556},{"month":2,"riseRate":0.5,"avgChangeRate":0.214631},{"month":3,"riseRate":0.375,"avgChangeRate":-0.032392},{"month":4,"riseRate":0.375,"avgChangeRate":-0.151083},{"month":5,"riseRate":0.625,"avgChangeRate":0.161904},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.047991},{"month":7,"riseRate":0.5,"avgChangeRate":0.018263},{"month":8,"riseRate":0.375,"avgChangeRate":-0.146061},{"month":9,"riseRate":0.5,"avgChangeRate":0.064501},{"month":10,"riseRate":0.375,"avgChangeRate":0.187824},{"month":11,"riseRate":0.125,"avgChangeRate":-0.10027},{"month":12,"riseRate":0.375,"avgChangeRate":-0.109516}],"exchange":"NASDAQ","name":"Outlook Therapeutics, Inc.","nameEN":"Outlook Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Outlook Therapeutics, Inc.,OTLK,Outlook Therapeutics, Inc.股票,Outlook Therapeutics, Inc.股票老虎,Outlook Therapeutics, Inc.股票老虎国际,Outlook Therapeutics, Inc.行情,Outlook Therapeutics, Inc.股票行情,Outlook Therapeutics, Inc.股价,Outlook Therapeutics, Inc.股市,Outlook Therapeutics, Inc.股票价格,Outlook Therapeutics, Inc.股票交易,Outlook Therapeutics, Inc.股票购买,Outlook Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况